EUVIMEDEUVIMED entdecken
Leserbrief

Response to the Letter by Dr. Parena Maheshwari Regarding Our Manuscript, “Asia‐Pacific Survey on the Management of Helicobacter pylori Infection”

Koji Otani iD, Dao Viet Hang, Rapat Pittayanon iD, Henry Liu, Kee Huat Chuah iD, John Hsiang, Ning Zhang, Akira Higashimori iD, Yasuhiro Fujiwara, Upper GI Focus Group of the APAGE‐ELC

Journal of Gastroenterology and Hepatology · 2025

DOI: 10.1111/jgh.70087 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of Gastroenterology and Hepatology, 2025. Verfasst von Koji Otani und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan. Hauptthemen laut MEDLINE: Helicobacter Infections, Helicobacter pylori, Anti-Bacterial Agents, Practice Patterns, Physicians'. Die Arbeit nennt 6 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We appreciate the constructive comments provided by Dr. Parena Maheshwari regarding our article, “Asia‐Pacific Survey on the Management of Helicobacter pylori Infection.” The objective of this study was to investigate the extent of overall agreement among clinicians in the Asia‐Pacific region regarding the management of H. pylori infection. Our findings highlight key challenges, including limited access to potassium‐competitive acid blockers, low implementation of antibiotic susceptibility tests, and continued reliance on empirical regimens. Although vonoprazan is widely used in Japan, its adoption elsewhere remains limited due to regulatory and economic barriers. Notably, only 14.3% of clinicians reported using susceptibility‐guided therapy, hindered by the decline in culture‐based methods, cost issues, and limited laboratory infrastructure. We emphasize the urgent need for expanded access to molecular diagnostic tools and cost‐effectiveness studies to inform future strategies. Subgroup analyses revealed regional variability; however, further studies are warranted to further examine specialty‐based and intra‐regional differences. Eradication therapy in pediatric and elderly populations also poses unique challenges. Concerns regarding long‐term safety limit standardized protocols in children, while in elderly patients, evidence for gastric cancer prevention, particularly in those aged ≥ 80 years, remains insufficient. We are encouraged by the interest our work has generated and believe that this exchange highlights critical areas for future research, including antimicrobial resistance surveillance, individualized treatment approaches, and strengthening of health system capacities. We hope this dialogue will facilitate further research and contribute to improved H. pylori management across the Asia‐Pacific region.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter InfectionsHelicobacter pyloriAnti-Bacterial AgentsPractice Patterns, Physicians'HumansAsiaSulfonamidesPyrrolesMicrobial Sensitivity TestsSurveys and Questionnaires

Stichwörter der Autor:innen

Asia‐Pacific regionHelicobacter pylorigastric cancerprimary preventionsecondary prevention

Substanzen

Anti-Bacterial Agents1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamineSulfonamidesPyrroles

Autor:innen und Institutionen

  • Department of Gastroenterology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
  • Internal Medicine Faculty, Hanoi Medical University, Hanoi, Vietnam.
  • Internal Medicine, King Chulalongkorn Memorial Hospital and Chulalongkorn University, Bangkok, Thailand.
  • Department of Medicine, Queen Elizabeth Hospital, King's Park, Hong Kong.
  • Gastroenterology and Hepatology Unit, Department of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
  • Mount Elizabeth Medical Centre, Richmond Gastroenterology Centre, Singapore.

ORCID-Profile: Koji Otani, Rapat Pittayanon, Kee Huat Chuah, Akira Higashimori

Zitieren

APA

Otani, K., Hang, D. V., Pittayanon, R., Liu, H., Chuah, K. H., Hsiang, J., Zhang, N., Higashimori, A., Fujiwara, Y., & Upper GI Focus Group of the APAGE‐ELC (2025). Response to the Letter by Dr. Parena Maheshwari Regarding Our Manuscript, “Asia‐Pacific Survey on the Management of Helicobacter pylori Infection”. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.70087

Vancouver

Otani K, Hang DV, Pittayanon R, Liu H, Chuah KH, Hsiang J, et al. Response to the Letter by Dr. Parena Maheshwari Regarding Our Manuscript, “Asia‐Pacific Survey on the Management of Helicobacter pylori Infection”. Journal of Gastroenterology and Hepatology. 2025. doi:10.1111/jgh.70087

BibTeX
@article{Otani2025,
  author = {Otani, Koji and Hang, Dao Viet and Pittayanon, Rapat and Liu, Henry and Chuah, Kee Huat and Hsiang, John and Zhang, Ning and Higashimori, Akira and Fujiwara, Yasuhiro and Upper GI Focus Group of the APAGE‐ELC, Upper GI Focus Group of the APAGE‐ELC},
  title = {Response to the Letter by Dr. Parena Maheshwari Regarding Our Manuscript, “Asia‐Pacific Survey on the Management of Helicobacter pylori Infection”},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2025},
  doi = {10.1111/jgh.70087}
}
Kostenlos starten →